Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Plos One|June 21, 2018
Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver diseasePik Eu Chang, George Boon Bee Goh, Wei Qiang Leow, et al.Singapore Medical Journal|January 1, 2020
Disseminated peritoneal leiomyomatosis: a devastating sequelae of unconfined laparoscopic morcellationHwee Leong Tan, Ye Xin Koh, Min Hoe Chew, et al.Scientific Reports|March 1, 2019
Quantification of hepatic steatosis in chronic liver disease using novel automated method of second harmonic generation and two-photon excited fluorescenceGeorge Boon-Bee Goh, Wei Qiang Leow, Shen Liang, et al.Digestive Diseases and Sciences|March 31, 2026
Safety of Statins in an Asian Cohort with Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver DiseaseWei-Lun Liou, Yiying Pei, Kevin Kim-Jun Teh, et al.Microbiology Insights|May 22, 2020
Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-UpChong Teik Lim, George Boon Bee Goh, Huihua Li, et al.Scientific Reports|February 10, 2022
A promising deep learning-assistive algorithm for histopathological screening of colorectal cancerCowan Ho, Zitong Zhao, Xiu Fen Chen, et al.Histopathology|June 7, 2024
Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challengesNatthawadee Laokulrath, Mihir Gudi, Syed Ahmed Salahuddin, et al.Liver Cancer|October 9, 2025
Immune and Histopathological Biomarkers for Prognosis and Neoadjuvant Immunotherapy Response in Intrahepatic CholangiocarcinomaN Jannah M Nasir, Edwin J C Chew, Kai Zhu, et al.Journal of Gastroenterology and Hepatology|June 20, 2020
Clinical profile of non-alcoholic fatty liver disease in nonobese patientsJohnathan Huey Ming Lum, Mark Chang Chuen Cheah, Wei Qiang Leow, et al.Diagnostics (Basel, Switzerland)|September 3, 2020
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical TrialsWei-Qiang Leow, Pierre Bedossa, Feng Liu, et al.Pageof 6